DexCom
DXCM
DXCM
725 hedge funds and large institutions have $33.1B invested in DexCom in 2021 Q1 according to their latest regulatory filings, with 91 funds opening new positions, 289 increasing their positions, 232 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
725
Holders Change
-3
Holders Change %
-0.41%
% of All Funds
12.77%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.11%
New
91
Increased
289
Reduced
232
Closed
86
Calls
$455M
Puts
$451M
Net Calls
+$3.81M
Net Calls Change
+$103M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$1.92B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$496M |
| 3 |
Morgan Stanley
New York
|
$861M |
| 4 |
Jennison Associates
New York
|
$611M |
| 5 |
JPMorgan Chase & Co
New York
|
$1.03B |
